LeMaitre Will Announce Fourth Quarter 2022 Earnings Results

BURLINGTON, Mass., Feb. 08, 2023 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its fourth quarter 2022...

ShotSpotter Sets Fourth Quarter and Full Year 2022

FREMONT, Calif., Feb. 08, 2023 (GLOBE NEWSWIRE) -- ShotSpotter, Inc. (NASDAQ: SSTI), a leader in precision-policing technology solutions that enable law...

Crown Crafts, Inc. to Announce Results for Third Quarter of

GONZALES, La., Feb. 08, 2023 (GLOBE NEWSWIRE) -- Crown Crafts, Inc. (NASDAQ-CM: CRWS) (the “Company”) today announced that it intends to release the...

CANON ADDS EOS R50 AND EOS R8 TO THE GROWING EOS R

Plus, Image Story Telling Through R-Mount Lenses Is Ramped Up With Additions of the New RF-S55-210mm F5-7.1 IS STM and RF24-50mm F4.5-6.3 IS STM Lenses...

Isoray Inc. and Viewpoint Molecular Targeting Inc. Announce

Company’s focus is on the advancement of cancer treatments using radiation, radiopharmaceuticals, and imaging technologies New corporate tagline and...

Tenaya Therapeutics to Participate in Upcoming Investor

SOUTH SAN FRANCISCO, Calif., Feb. 07, 2023 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a...

Inari Medical to Announce Fourth Quarter and Full Year 2022

IRVINE, Calif., Feb. 07, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and...

Mondelēz International to Present at CAGNY Conference on

CHICAGO, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Mondelēz International, Inc. (Nasdaq: MDLZ) announced that Dirk Van de Put, Chairman & CEO, Luca...

Outlook Therapeutics® to Present at the SVB Securities

– Russ Trenary, President and Chief Executive Officer of Outlook Therapeutics to present on Tuesday, February 14th at 4:20 PM ET –...